Filed: 8/14/2026ACC: 0000905148-26-003741
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $519.38M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$519.38M
Total AUM (reported)
34.05M
Total Shares
Allocation by class
COM$514.64M99.1%
COM NEW$4.74M0.9%
Portfolio Concentration
Top 3$432.15M83.2%
4–10$87.23M16.8%
Top 3 weight
83.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 34.05M
Sole
Full voting authority
34.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
PHARVARIS N V
SOLEShares4.64M
TypeSH
Market value$160.57M
30.92%
Sole
4.64M
Shared
0.00
None
0.00
PARABILIS MEDICINES INC
SOLEShares5.27M
TypeSH
Market value$144.15M
27.75%
Sole
5.27M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares4.53M
TypeSH
Market value$127.43M
24.53%
Sole
4.53M
Shared
0.00
None
0.00
ACHIEVE LIFE SCIENCE INC
SOLEShares5.91M
TypeSH
Market value$38.62M
7.44%
Sole
5.91M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares12.88M
TypeSH
Market value$26.67M
5.14%
Sole
12.88M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares472.19K
TypeSH
Market value$17.19M
3.31%
Sole
472.19K
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares337.70K
TypeSH
Market value$4.74M
0.91%
Sole
337.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHARVARIS N VSOLE | COM | 4.64M | SH | $160.57M 30.92% | 4.64M | 0.00 | 0.00 |
PARABILIS MEDICINES INCSOLE | COM | 5.27M | SH | $144.15M 27.75% | 5.27M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 4.53M | SH | $127.43M 24.53% | 4.53M | 0.00 | 0.00 |
ACHIEVE LIFE SCIENCE INCSOLE | COM | 5.91M | SH | $38.62M 7.44% | 5.91M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 12.88M | SH | $26.67M 5.14% | 12.88M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 472.19K | SH | $17.19M 3.31% | 472.19K | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM NEW | 337.70K | SH | $4.74M 0.91% | 337.70K | 0.00 | 0.00 |